Therapeutic vaccines for non-Hodgkin B-cell lymphoma
/in International Publications, Malignant LymphomaExpression of a soluble TGF-beta receptor by tumor cells enhances dendritic cell/tumor fusion vaccine efficacy
/in Breast Cancer, International PublicationsOvarian cancer detection and treatment: current situation and future prospects
/in International Publications, Ovarian CancerOptimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy
/in Dendritic Cells, International PublicationsBiological approaches to therapy of pancreatic cancer
/in International Publications, Pancreatic CancerReview of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters
/in International Publications, Malignant MelanomaRecombinant Newcastle disease virus as a vaccine vector for cancer therapy
/in International Publications, Newcastle Disease VirusNovel therapeutic strategies for treating esophageal adenocarcinoma: the potential of dendritic cell immunotherapy and combinatorial regimens
/in Dendritic Cells, Esophageal Carcinoma, International PublicationsA two-state cell damage model under hyperthermic conditions: theory and in vitro experiments
/in Hyperthermia, International Publications, Prostate Cancer
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer